Similarly, PD-L2 can be induced by the adaptive immune resistance mechanism, depending on the milieu of inflammatory cytokines in the tumor microenvironment; for example, IFN-γ, IL-4 and colony-stimulating factor 2 (CSF-2) upregulate PD-L211. Here, IFNG is linked to neoplasm.